Influenza vaccination coverage in Japan [11]

Lancet

Volumn 362, Issue 9397, 2003, Pages 1767-

  Lee, Jung Su ^a   Kawakubo, Kiyoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYORITSU WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

COST EFFECTIVENESS ANALYSIS; DRUG COST; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LETTER; NURSING HOME; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; SIDE EFFECT; VIRUS INHIBITION; VIRUS PNEUMONIA;

EID: 0344120800     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14870-2     Document Type: Letter

References (3)

1. CDC. Recommendations of the Advisory Committee on immunization practices, prevention and control of influenza. MMWR Morb Mortal Wkly Rep 2003; 52: 1-36. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5208a1.htm (accessed Oct 21, 2003).
2. Hirota Y., Kaji M. Scepticism about influenza vaccine efficacy in Japan. Lancet. 344:1994;408-409.
3. National Institute of Infectious Diseases. Infectious agents surveillance report: influenza, 2001/02 season, Japan. IASR 2002; 23: 307-13. http://idsc.nih.go.jp/iasr/23/274/tpc274-j.html/ (accessed Sept 23, 2003).